Newsroom
displaying: 18 press releases
MODERNA’S MRNA RSV VACCINE RECEIVES HEALTH CANADA APPROVAL FOR ADULTS AGED 60 YEARS AND OVER
2024-11-08
COMPLETION OF MODERNA'S VACCINE PRODUCTION LINE AT NOVOCOL PHARMA ENHANCES ONTARIO'S BIOMANUFACTURING STRENGTH
2024-11-01
MODERNA RECEIVES HEALTH CANADA APPROVAL FOR UPDATED COVID-19 VACCINE TARGETING KP.2 VARIANT OF SARS-COV-2 FOR AGES 6 MONTHS AND OLDER
2024-09-17
MODERNA'S CANADIAN MANUFACTURING FACILITY RECEIVES DRUG ESTABLISHMENT LICENSE FROM HEALTH CANADA
2024-09-09
MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY
2024-02-23
MODERNA FILES FOR HEALTH CANADA REVIEW OF ITS RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE, mRNA-1345
2023-10-05
ROGER-KETCHA NGASSAM JOINS MODERNA TO LEAD CANADIAN mRNA VACCINE MANUFACTURING
2023-09-28
MODERNA RECEIVES HEALTH CANADA AUTHORIZATION FOR UPDATED COVID-19 VACCINE FOR AGES SIX MONTHS AND OLDER
2023-09-12
MODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE
2023-06-29